334 related articles for article (PubMed ID: 35995144)
1. Neuro-ophthalmological Presentation of Optic Neuritis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Lin TY; Asseyer S; Buenrostro GS; Feldmann K; Hamann S; Paul F; Zimmermann HG
Klin Monbl Augenheilkd; 2022 Nov; 239(11):1305-1314. PubMed ID: 35995144
[TBL] [Abstract][Full Text] [Related]
2. [Typical and atypical optic neuritis].
Sheremet NL; Eliseeva DD; Kalashnikova AK; Zakharova MN
Vestn Oftalmol; 2023; 139(6):175-182. PubMed ID: 38235645
[TBL] [Abstract][Full Text] [Related]
3. The neuro-ophthalmological manifestations of NMOSD and MOGAD-a comprehensive review.
Moheb N; Chen JJ
Eye (Lond); 2023 Aug; 37(12):2391-2398. PubMed ID: 36928226
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
Banwell B; Bennett JL; Marignier R; Kim HJ; Brilot F; Flanagan EP; Ramanathan S; Waters P; Tenembaum S; Graves JS; Chitnis T; Brandt AU; Hemingway C; Neuteboom R; Pandit L; Reindl M; Saiz A; Sato DK; Rostasy K; Paul F; Pittock SJ; Fujihara K; Palace J
Lancet Neurol; 2023 Mar; 22(3):268-282. PubMed ID: 36706773
[TBL] [Abstract][Full Text] [Related]
5. Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Gericke FC; Hanson JVM; Hackenberg A; Gerth-Kahlert C
Eur J Paediatr Neurol; 2024 Jan; 48():113-120. PubMed ID: 38217965
[TBL] [Abstract][Full Text] [Related]
6. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
7. Clinical and radiographic features of a cohort of adult and pediatric subjects in the Pacific Northwest with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Martin K; Srikanth P; Kanwar A; Falardeau J; Pettersson D; Yadav V
Mult Scler Relat Disord; 2024 Jan; 81():105130. PubMed ID: 37979410
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review.
Feizi P; Sharma K; Pasham SR; Nirwan L; Joseph J; Jaiswal S; Sriwastava S
J Neuroimmunol; 2022 Oct; 371():577939. PubMed ID: 35939945
[TBL] [Abstract][Full Text] [Related]
9. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
[TBL] [Abstract][Full Text] [Related]
10. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review.
Kaushik M; Burdon MA
J Neuroophthalmol; 2021 Dec; 41(4):e786-e795. PubMed ID: 33870945
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.
Gospe SM; Chen JJ; Bhatti MT
Eye (Lond); 2021 Mar; 35(3):753-768. PubMed ID: 33323985
[TBL] [Abstract][Full Text] [Related]
13. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
Chen JJ; Bhatti MT
Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
[TBL] [Abstract][Full Text] [Related]
14. Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review.
Lin TY; Chien C; Lu A; Paul F; Zimmermann HG
Expert Rev Neurother; 2021 Oct; 21(10):1101-1123. PubMed ID: 34551653
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD).
Mewes D; Kuchling J; Schindler P; Khalil AAA; Jarius S; Paul F; Chien C
Klin Monbl Augenheilkd; 2022 Nov; 239(11):1315-1324. PubMed ID: 36410333
[TBL] [Abstract][Full Text] [Related]
16. Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report.
Kolcava J; Rajdova A; Vlckova E; Stourac P; Bednarik J
BMC Neurol; 2022 Aug; 22(1):313. PubMed ID: 36002821
[TBL] [Abstract][Full Text] [Related]
17. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease.
Li EC; Zheng Y; Cai MT; Lai QL; Fang GL; Du BQ; Shen CH; Zhang YX; Wu LJ; Ding MP
Epilepsia; 2022 Sep; 63(9):2173-2191. PubMed ID: 35652436
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review.
Tanaka K; Kezuka T; Ishikawa H; Tanaka M; Sakimura K; Abe M; Kawamura M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686172
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis.
Tajfirouz DA; Bhatti MT; Chen JJ
Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369
[TBL] [Abstract][Full Text] [Related]
20. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]